Klotho Neurosciences Faces Delisting Notice

Ticker: GRMLW · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1907223

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

Related Tickers: KLTO

TL;DR

Klotho Neurosciences got a notice about possibly getting delisted.

AI Summary

Klotho Neurosciences, Inc. filed an 8-K on February 24, 2025, reporting a notice of delisting or failure to meet continued listing standards as of February 14, 2025. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp., is based in New York.

Why It Matters

This filing indicates potential issues with Klotho Neurosciences' ability to remain listed on its current exchange, which could impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation as a publicly traded entity.

Key Players & Entities

FAQ

What specific listing standard did Klotho Neurosciences fail to meet?

The filing does not specify the exact listing standard that Klotho Neurosciences failed to meet, only that it received a notice of delisting or failure to satisfy a continued listing rule or standard.

What is the date of the event triggering this 8-K filing?

The earliest event reported in this filing occurred on February 14, 2025.

When was Klotho Neurosciences previously known by other names?

The company was formerly known as ANEW Medical, Inc. (name change on June 24, 2024) and Redwoods Acquisition Corp. (name change on January 27, 2022).

What is the company's primary business classification?

Klotho Neurosciences, Inc. is classified under Standard Industrial Classification code 2836, which is for Biological Products (No Diagnostic Substances).

Where is Klotho Neurosciences, Inc. headquartered?

The company's business address is listed as 1115 Broadway, 12th Floor, New York, NY 10010.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing